View in EDS HTML Full Text PDF Full Text

A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion.

Saved in:
Bibliographic Details
Title: A genetically engineered therapeutic lectin inhibits human influenza A virus infection and sustains robust virus-specific CD8 T cell expansion.
Authors: Yu, Meng1 (AUTHOR), Lin, Ang1 (AUTHOR), Baharom, Faezzah1 (AUTHOR), Li, Shuijie2 (AUTHOR), Legendre, Maureen3 (AUTHOR), Covés-Datson, Evelyn3,4 (AUTHOR), Sohlberg, Ebba5 (AUTHOR), Schlisio, Susanne2 (AUTHOR), Loré, Karin1 (AUTHOR), Markovitz, David M.3,6 (AUTHOR), Smed-Sörensen, Anna1 (AUTHOR) anna.smed.sorensen@ki.se
Source: PLoS Pathogens. 5/7/2025, Vol. 21 Issue 5, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:15537366
DOI:10.1371/journal.ppat.1013112